Challenges and risks of using Omega-3 fatty acids in the supportive treatment of depression
DOI:
https://doi.org/10.12775/QS.2025.39.58324Keywords
omega-3 fatty acids, risks, challengesAbstract
Introduction: Omega-3 fatty acids, including α-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), are essential nutrients with anti-inflammatory and neuroprotective properties. EPA has demonstrated potential in mitigating depression by enhancing neurotransmitter synthesis, including dopamine and serotonin. However, gastrointestinal side effects, fatigue, anxiety, contamination risks (e.g., mercury, lead), and variability in supplement quality and accessibility pose significant challenges. Addressing these issues is essential to optimize the safe and effective therapeutic use of omega-3 fatty acids in depression management.
Material and methods of research: The materials and literature was collected using searches in Pubmed, research gate and Google Scholar databases and references from retrieved articles.
Results: Omega-3 fatty acids, particularly EPA and DHA, show promise in treating depression due to their anti-inflammatory and neuroprotective effects. However, challenges include differing mechanisms, side effects, contamination risks, and inconsistent supplement quality. Short trials often miss long-term effects, and limited access and population diversity further hinder progress. Rigorous research and improved regulation are essential to unlock their full therapeutic potential.
Conclusion: Omega-3 fatty acids, particularly EPA, show promise as a supportive treatment for depression due to their role in neurotransmitter production and inflammation control. However, challenges such as side effects, contamination risks, and inconsistent supplement quality necessitate strict monitoring, improved standards, and broader access to high-quality products to ensure their safe and effective use in depression management.
References
1. Sicińska, Paulina, et al. ‘Suplementacja kwasami omega w różnych chorobach’. Postępy Higieny i Medycyny Doświadczalnej, vol. 69, 2015. www.son.uni.lodz.pl, https://doi.org/10.5604/17322693.1162673.
2. Krupa, Kristina, et al. ‘Omega-3 Fatty Acids’. StatsPearls, Jan. 2020, https://nsuworks.nova.edu/hpd_facarticles/171.
3. Surette, Marc E. ‘The Science behind Dietary Omega-3 Fatty Acids’. CMAJ: Canadian Medical Association Journal = Journal de l’Association Medicale Canadienne, vol. 178, no. 2, Jan. 2008, pp. 177–80. PubMed, https://doi.org/10.1503/cmaj.071356.
4. DiNicolantonio, James J., and James O’Keefe. ‘The Importance of Maintaining a Low Omega-6/Omega-3 Ratio for Reducing the Risk of Autoimmune Diseases, Asthma, and Allergies’. Missouri Medicine, vol. 118, no. 5, 2021, pp. 453–59. PubMed Central, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504498/
5. Innes, Jacqueline K., and Philip C. Calder. ‘Omega-6 Fatty Acids and Inflammation’. Prostaglandins, Leukotrienes, and Essential Fatty Acids, vol. 132, May 2018, pp. 41–48. PubMed, https://doi.org/10.1016/j.plefa.2018.03.004.
6. Vanschoonbeek, Kristof, et al. ‘Variable Hypocoagulant Effect of Fish Oil Intake in Humans: Modulation of Fibrinogen Level and Thrombin Generation’. Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 9, Sept. 2004, pp. 1734–40. PubMed, https://doi.org/10.1161/01.ATV.0000137119.28893.0b.
7. Wani, Ab Latif, et al. ‘Omega-3 Fatty Acids and the Treatment of Depression: A Review of Scientific Evidence’. Integrative Medicine Research, vol. 4, no. 3, Sept. 2015, pp. 132–41. PubMed Central, https://doi.org/10.1016/j.imr.2015.07.003.
8. Mehdi, Seema, et al. ‘Omega-3 Fatty Acids Supplementation in the Treatment of Depression: An Observational Study’. Journal of Personalized Medicine, vol. 13, no. 2, Jan. 2023, p. 224. PubMed Central, https://doi.org/10.3390/jpm13020224.
9. Krawczyk, Kamila, and Janusz Rybakowski. ‘[Augmentation of antidepressants with unsaturated fatty acids omega-3 in drug-resistant depression]’. Psychiatria Polska, vol. 46, no. 4, 2012, pp. 585–98.
10. Jazayeri, Shima, et al. ‘Comparison of Therapeutic Effects of Omega-3 Fatty Acid Eicosapentaenoic Acid and Fluoxetine, Separately and in Combination, in Major Depressive Disorder’. The Australian and New Zealand Journal of Psychiatry, vol. 42, no. 3, Mar. 2008, pp. 192–98. PubMed, https://doi.org/10.1080/00048670701827275.
11. Lucas, Michel, et al. ‘Ethyl-Eicosapentaenoic Acid for the Treatment of Psychological Distress and Depressive Symptoms in Middle-Aged Women: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial2’. The American Journal of Clinical Nutrition, vol. 89, no. 2, Feb. 2009, pp. 641–51. ScienceDirect, https://doi.org/10.3945/ajcn.2008.26749.
12. Kumar, Manoj, et al. ‘A Review on Heavy Metal-Induced Toxicity in Fishes: Bioaccumulation, Antioxidant Defense System, Histopathological Manifestations, and Transcriptional Profiling of Genes’. Journal of Trace Elements in Medicine and Biology, vol. 83, May 2024, p. 127377. ScienceDirect, https://doi.org/10.1016/j.jtemb.2023.127377.
13. Burca, Nicole, and Ronald Ross Watson. ‘Chapter 36 - Fish Oil Supplements, Contaminants, and Excessive Doses’. Omega-3 Fatty Acids in Brain and Neurological Health, edited by Ronald Ross Watson and Fabien De Meester, Academic Press, 2014, pp. 447–54. ScienceDirect, https://doi.org/10.1016/B978-0-12-410527-0.00036-3.
14. Epure, Alina, et al. Correlation between the Presence of Metals with Potential for Intoxication, Omega 3 Deficiency, Increased Omega 6: Omega 3 Ratio and Their Associated Symptoms. | EBSCOhost. 1 Apr. 2022, https://doi.org/10.37897/RMJ.2022.2.5.
15. Coletta, Jaclyn M., et al. ‘Omega-3 Fatty Acids and Pregnancy’. Reviews in Obstetrics and Gynecology, vol. 3, no. 4, 2010, pp. 163–71. PubMed Central, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046737/.
16. Cameron-Smith, David, et al. ‘Fishing for Answers: Is Oxidation of Fish Oil Supplements A?’ Journal of Nutritional Science, vol. 4, Nov. 2015, p. e36. PubMed Central, https://doi.org/10.1017/jns.2015.26.
17. Albert, Benjamin B., et al. ‘Oxidation of Marine Omega-3 Supplements and Human Health’. BioMed Research International, vol. 2013, 2013, p. 464921. PubMed Central, https://doi.org/10.1155/2013/464921.
18. Wang, Jiankang, et al. ‘Stability and Stabilization of Omega-3 Oils: A Review’. Trends in Food Science & Technology, vol. 118, Dec. 2021, pp. 17–35. ScienceDirect, https://doi.org/10.1016/j.tifs.2021.09.018.
19. Pasini, Federica, et al. ‘Assessment of Lipid Quality in Commercial Omega-3 Supplements Sold in the French Market’. Biomolecules, vol. 12, no. 10, Sept. 2022, p. 1361. PubMed Central, https://doi.org/10.3390/biom12101361.
20. Schuchardt, Jan Philipp, et al. ‘Omega-3 World Map: 2024 Update’. Progress in Lipid Research, vol. 95, July 2024, p. 101286. ScienceDirect, https://doi.org/10.1016/j.plipres.2024.101286.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Joanna Orzechowska, Michał Orzechowski, Paulina Fijałek, Jan Karczmarz, Aleksandra Paprocka, Marika Gutowska, Agnieszka Kosińska, Urszula Świrk, Wiktoria Belcarz, Karolina Kalinowska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 162
Number of citations: 0
